Feasibility and Safety of the Distal Transradial Artery for Coronary Diagnostic or Interventional Catheterization

Table 1

Baseline characteristics of the dTRA and TRA groups.

		dTRA	TRA
Subjects, n		450	450
Age, years		55.28 ± 10.59	58.81 ± 9.42	0.075
Males		205 (45.56)	225 (50.00)	0.386
Body mass index, kg/m^2		24.06 ± 3.58	24.36 ± 2.64	0.230
SBP at the cath lab, mmHg		129.15 ± 13.78	127.01 ± 14.61	0.190
DBP at the cath lab, mmHg		74.51 ± 11.08	75.46 ± 10.98	0.091
Heart rate at the cath lab, bpm		76.29 ± 12.09	76.89 ± 11.56	0.810
Hypertension		112 (24.89)	113 (25.11)	0.856
Diabetes mellitus		48 (10.67)	56 (12.44)	0.166
Current smoking		124 (27.56)	101 (22.44)	0.144
Previous cardiac catheterization		32 (7.11)	33 (7.33)	0.980
eGFR		80.45 ± 22.61	77.3 ± 26.53	0.528
LVEF, %		56.5 ± 12.6	57.3 ± 10.5	0.650
Diagnostic catheterization		224 (49.78)	234 (52.00)	0.635
Interventional catheterization	STEMI	48 (10.67)	56 (12.44)	0.537
	NSTEMI-ACS	178 (39.56)	160 (35.56)	0.288
Medical treatment	APT	440 (97.78)	439 (97.56)	0.788
	Anticoagulation	55 (12.22)	52 (11.56)	0.808

Reported as n (%), unless indicated otherwise. ACS, acute coronary syndrome; APT, antiplatelet therapy; eGFR, estimated glomerular filtration rate; NSTEMI, non-ST-elevation myocardial infarction.